Page 11 - P18-0863_Llibret_EPOC_paciente_V7_0pdf

REFERENCIAS

1. Organización Mundial de la Salud. Burden of COPD. Disponible en: 10. van der Molen T, et al. COPD management: role of symptom
http://www.who.int/respiratory/copd/burden/en/. assessment in routine clinical practice. Int J Chron Obstruct
Pulmon Dis. 2013;8:461-71.
2. Global Initiative for Chronic Obstructive Lung Disease. Global
strategy for the diagnosis, management, and prevention of 11. Controlando la EPOC... Fundación Española del Pulmón
chronic obstructive pulmonary disease. 2018 report. Disponible – SEPAR. Editorial Respira. Disponible en: http://issuu.
en: http://goldcopd.org/wp-content/uploads/2017/11/GOLD- com/separ/docs/controlando_la_epoc.?mode=window&-
2018-v6.0-FINAL-revised-20-Nov_WMS.pdf. backgroundColor=%23222222.
3. Convivir con la EPOC. Fundación Española del Pulmón – SEPAR. 12. Kwak MJ, et al. National Trends in Smoking Cessation Medication
Editorial Respira. Disponible en: https://www.dropbox.com/s/ Prescriptions for Smokers With Chronic Obstructive Pulmonary
okvkok9vmb2rx1c/Convivir%20con%20la%20EPOC.pdf?dl=. Disease in the United States, 2007-2012. J Prev Med Public
Health. 2018;51(5):257-262.
4. Enfermedad pulmonar obstructiva crónica (EPOC). Organización
Mundial de la Salud. 2017. Disponible en: http://www.who.int/es/ 13. Lambert AA, et al. Obesity Is Associated With Increased Morbidity
news-room/fact-sheets/detail/chronic-obstructive-pulmonary- in Moderate to Severe COPD. Chest. 2017;151(1):68-77.
disease-(copd). 14. Macario CC, et al. La disnea en la EPOC. Arch Bronconeumol.
5. GBD 2015 Risk Factors Collaborators. Global, regional, and 2005;41(Supl 3):24-32.
national comparative risk assessment of 79 behavioural,
environmental and occupational, and metabolic risks or clusters
of risks, 1990-2015: a systematic analysis for the Global Burden of
Disease Study 2015. Lancet. 2016;388:1659-1724.
6. Mathers CD, et al. Projections of Global Mortality and Burden of
Disease from 2002 to 2030. PLoS Med. 2006;3:e442.
7. Soriano JB, et al. Recent trends in COPD prevalence in Spain:
a repeated cross-sectional survey 1997-2007. Eur Respir J.
2010;36:758-765.

8. Alonso T, et al. Chronic obstructive pulmonary disease in Women.
Is it Different? Arch Bronconeumol. 2017;53(4):222-227.

9. Miravitlles M, et al. Guía española de la enfermedad pulmonar
obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico
en fase estable. Arch Broncolneumol. 2017;53:291-356.